DUTCH ASSET Corp Takes Position in SPDR S&P Biotech ETF $XBI

DUTCH ASSET Corp acquired a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 4,323 shares of the exchange traded fund’s stock, valued at approximately $527,000.

A number of other hedge funds have also made changes to their positions in the business. AQR Capital Management LLC raised its stake in shares of SPDR S&P Biotech ETF by 77.1% during the 1st quarter. AQR Capital Management LLC now owns 4,978 shares of the exchange traded fund’s stock worth $404,000 after buying an additional 2,167 shares in the last quarter. Marshall Wace LLP boosted its stake in shares of SPDR S&P Biotech ETF by 102.3% in the second quarter. Marshall Wace LLP now owns 4,023 shares of the exchange traded fund’s stock valued at $334,000 after buying an additional 179,029 shares in the last quarter. The Manufacturers Life Insurance Company purchased a new stake in shares of SPDR S&P Biotech ETF in the second quarter valued at approximately $260,000. Ameriprise Financial Inc. grew its holdings in SPDR S&P Biotech ETF by 123.0% during the second quarter. Ameriprise Financial Inc. now owns 872,796 shares of the exchange traded fund’s stock worth $72,542,000 after acquiring an additional 481,408 shares during the period. Finally, EP Wealth Advisors LLC grew its holdings in SPDR S&P Biotech ETF by 3.7% during the second quarter. EP Wealth Advisors LLC now owns 5,379 shares of the exchange traded fund’s stock worth $446,000 after acquiring an additional 193 shares during the period.

SPDR S&P Biotech ETF Stock Performance

SPDR S&P Biotech ETF stock opened at $140.72 on Friday. The stock has a 50-day moving average price of $133.56 and a 200 day moving average price of $127.70. SPDR S&P Biotech ETF has a 52 week low of $80.90 and a 52 week high of $143.46. The stock has a market cap of $8.98 billion, a PE ratio of 11.47 and a beta of 0.85.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.